CAS: 90004-09-4; 7-Aminoquinazolin-4(1H)-One

结构式图片

上下游产品

CAS号20872-93-9 7-硝基喹唑啉-4(3H)-酮 | CAS号619-17-0 2-氨基-4-硝基苯甲酸 | CAS号202197-77-1 7-碘喹唑啉-4(1H)-酮

合成工艺路线路线简述

  • 20872-93-9 = 90004-09-4
    反应条件:1.1 Reagents: Ammonium Formate Catalysts: Palladium Solvents: Methanol; 10 Min,65 °C
    标题:Efficient Synthesis Of Thiazoloquinazolinone Derivatives
    作者:Alexandre,Francois-Rene; Berecibar,Amaya; Wrigglesworth,Roger; Besson,Thierry
    参考文献:Tetrahedron Letters 日期:2003 卷标:44(24) 页码:4455-4458]

    86222-55-1 = 90004-09-4
    反应条件:1.1 Reagents: Iron,Ammonium Chloride Solvents: Ethanol; 4 H,Reflux
    标题:Structure-Based Drug Design,Synthesis And Screening Of Mmaa1 Inhibitors As Novel Anti-Tb Agents
    作者:Veeravarapu,Hymavathi; Malkhed,Vasavi; Mustyala,Kiran Kumar; Vadija,Rajender; Malikanti,Ramesh; Et Al
    参考文献:Molecular Diversity 日期:2021 卷标:25(1) 页码:351-366]

    20872-93-9 = 90004-09-4
    反应条件:1.1 Reagents: Tin Dichloride Dihydrate Solvents: Ethyl Acetate; 8 H,Reflux; Reflux -> Rt1.2 Reagents: Sodium Carbonate Solvents: Water; Rt
    标题:Synthesis And Sar Optimization Of Quinazolin-4(3H)-Ones As Poly(Adp-Ribose)Polymerase-1 Inhibitors
    作者:Kulkarni,Shridhar S.; Singh,Satyakam; Shah,Janki R.; Low,Woon-Kai; Talele,Tanaji T.
    参考文献:European Journal Of Medicinal Chemistry 日期:2012 卷标:50 页码:264-273]

    20872-93-9 = 90004-09-4
    反应条件:1.1 Reagents: Hydrogen Catalysts: Palladium Solvents: Methanol,Dimethylformamide
    标题:Substituted 2H-Isoquinolin-1-One As Potent Rho-Kinase Inhibitors. Part 1: Hit-To-Lead Account
    作者:Wu,Frank; Buettner,Frank H.; Chen,Rhonda; Hickey,Eugene; Jakes,Scott; Et Al
    参考文献:Bioorganic & Medicinal Chemistry Letters 日期:2010 卷标:20(11) 页码:3235-3239
📜2-氨基-4-硝基苯甲酸置于palladium 10% On Activated Carbon,氢气体系中,用 乙醇 作为反应溶剂,化学反应生成 7-氨基喹唑啉-4-醇
参考文献:作为神经保护剂的药用化合物
标题:作为神经保护剂的药用化合物
摘要:本发明公开了一类作为神经保护剂的药用化合物,其为神经元型一氧化氮合酶‑突触后密度蛋白‑95(nnos‑psd95)的解耦联剂,其为具有通式(ⅰ)苯环衍生物或其药学上可接受的盐.本申请进一步公开了该类化合物的制备方法以及其用于预防和治疗受神经元损伤影响引起的疾病的用途.

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


参考文献:10.1007/s11030-020-10107-0
摘要:Veeravarapu H, Malkhed V, Mustyala KK, Vadija R, Malikanti R, Vuruputuri U, Muthyala MKK. Structure-based drug design, synthesis and screening of MmaA1 inhibitors as novel anti-TB agents. Mol Divers. 2021 Feb;25(1):351–66. doi: 10.1007/s11030-020-10107-0.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知